Ticker
AUTLCompany Name
AUTOLUS THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 661.63M | $ -227.78M | -34.43% |
3/31/2025 | $ 687.05M | $ -238.13M | -34.66% |
12/31/2024 | $ 728.05M | $ -220.66M | -30.31% |
9/30/2024 | $ 778.14M | $ -270.23M | -34.73% |
6/30/2024 | $ 816.53M | $ -233.98M | -28.66% |
3/31/2024 | $ 861.86M | $ -221.26M | -25.67% |
12/31/2023 | $ 335.34M | $ -208.38M | -62.14% |
9/30/2023 | $ 373.75M | $ -158.16M | -42.32% |
6/30/2023 | $ 416.04M | $ -155.08M | -37.28% |
3/31/2023 | $ 425.04M | $ -151.59M | -35.66% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for AUTOLUS THERAPEUTICS PLC is calculated as follows: Net Inc. Cmn. [ $ -140.18M ] / Inv. Capital [ $ 289.68M ]
(=) ROIC [ -48.39% ]
Minimum
Sep 30, 2022
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.69% |
median | 3.39% |
std | 15.18% |